Igg Chronic Antibiody
Human Chronic Myeloid Leukemia PB Plasma (Chronic Phase) |
|||
| ABC-TC3364 | AcceGen | 1 vial | Ask for price |
|
Description: Chronic Myeloid Leukemia-PB Plasma is obtained by centrifuging Chronic Myeloid Leukemia peripheral blood. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia plasma is available in the chronic phase and accelerated or blast crisis phase. |
|||
Igg Antibody Laboratories manufactures the igg chronic antibiody reagents distributed by Genprice. The Igg Chronic Antibiody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Igg products are available in stock. Specificity: Igg Category: Chronic Group: Antibiody
True north Cryobox1.5/2mLNatural |
||
| Scientific Laboratory Supplies | PK10 | EUR 129.6 |
True Blue Diaceturate Salt |
||
| Toronto Research Chemicals | 100mg | EUR 15000 |
|
Description: 108321-12-6 |
||
Human Chronic Myeloid Leukemia Bone Marrow Plasma (Chronic Phase) |
||
| AcceGen | 1 vial | Ask for price |
|
Description: Chronic Myeloid Leukemia-Bone Marrow plasma is obtained by centrifugation of the Chronic Myeloid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia-Bone Marrow plasma is available in chronic phase and accelerated or blast crisis phase. |
||
Human Chronic Myeloid Leukemia Bone Marrow CD34+ Cells(Chronic Phase) |
||
| AcceGen | 1 vial | Ask for price |
|
Description: Chronic Myeloid Leukemia-Bone Marrow-CD34+ Cells are isolated from the bone marrow using a direct CD34 MicroBead labeling system. Chronic Myeloid Leukemia-Bone Marrow-CD34+ Cells are available in the chronic phase and the acceleration or blast crisis phase. |
||
Human Chronic Myeloid Leukemia Bone Marrow Mononuclear Cells (Chronic Phase) |
||
| AcceGen | 1 vial | Ask for price |
|
Description: Chronic Myeloid Leukemia-Bone Marrow-Mononuclear Cells are isolated by diluting Chronic Myeloid Leukemia bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Chronic Myeloid LeukemiaMononuclear Cells can be processed further to isolate subpopulations. Chronic Myeloid Leukemia-Bone MarrowMononuclear Cells are available in either the chronic phase or accelerated/blast crisis phase. |
||
Esophageal mucous chronic inflammation |
||
| TissueArray | each | EUR 348 |
|
Description: Esophageal mucous chronic inflammation, esophageal intraepithelial neoplasia, esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 60cases/ 120cores, |
||
True Blue (TB) Diaceturate Salt |
||
| Polysciences Europe GmbH | 1mg | Ask for price |
|
Description: 108321-12-6 |
||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC552046-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC612035-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC612035-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC612046-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC612046-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC432035-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC432035-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC432046-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC432046-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC052035-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC052035-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC052046-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC052046-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNCA2035-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), APC conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNCA2046-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), APC conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNCAP2035-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNCAP2035-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||